Healthy Measureshttps://sciencebusiness.net/health
en Could medicines cause more side effects than once thought?https://sciencebusiness.net/healthy-measures/news/could-medicines-cause-more-side-effects-once-thought
<span property="schema:name" class="field-wrapper"> Could medicines cause more side effects than once thought?</span>
<span class="field-wrapper" rel="schema:author"><span lang="" about="https://sciencebusiness.net/user/9" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">Florin</span></span>
<span property="schema:dateCreated" content="2018-12-17T09:38:55+00:00" class="field-wrapper">17 Dec 2018</span>
<div class="image field field-node--field-image field-name-field-image field-type-image field-label-hidden">
<div class="field-items">
<div class="field-item"> <img property="schema:image" src="https://sciencebusiness.net/sites/default/files/styles/article/public/2018-12/imi%20logo%20wide_4_0.jpg?itok=a8Wmp_gF" width="1050" height="450" alt="" typeof="foaf:Image" /></div>
</div>
</div>
Mon, 17 Dec 2018 09:38:55 +0000Florin51199 at https://sciencebusiness.netDespite rapid innovation, UK patients wait up to 14 years for new cancer drugshttps://sciencebusiness.net/healthy-measures/news/despite-rapid-innovation-uk-patients-wait-14-years-new-cancer-drugs
<span property="schema:name" class="field-wrapper">Despite rapid innovation, UK patients wait up to 14 years for new cancer drugs</span>
<div class="field-wrapper field field-node--field-author field-name-field-author field-type-entity-reference field-label-hidden">
By
<span class="field-item"><a href="https://sciencebusiness.net/author/eanna-kelly" hreflang="en">Éanna Kelly</a></span></div>
<span class="field-wrapper" rel="schema:author"><span lang="" about="https://sciencebusiness.net/user/9" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">Florin</span></span>
<span property="schema:dateCreated" content="2018-12-04T11:05:53+00:00" class="field-wrapper">04 Dec 2018</span>
<div class="image field field-node--field-image field-name-field-image field-type-image field-label-hidden">
<div class="field-items">
<div class="field-item"> <img property="schema:image" src="https://sciencebusiness.net/sites/default/files/styles/article/public/2018-12/cancer-drugs-reserach.jpg?itok=PQf_eQPf" width="1050" height="450" alt="" typeof="foaf:Image" /></div>
</div>
</div>
<div property="schema:text" class="body field field-node--body field-name-body field-type-text-with-summary field-label-hidden">
<div class="field-items">
<div property="schema:text" class="field-item"><p><span><span><span>Patients are having to wait longer for innovative new drugs, with red tape covering clinical trials, regulation and approvals among the factors to blame, according to a report published Tuesday by the UK’s Institute of Cancer Research (ICR).</span></span></span></p>
<p><span><span><span>The analysis found that advances in cancer science have driven a big increase in the numbers of treatments developed, but that measure designed to speed up access for patients are not working.</span></span></span></p>
<p><span><span><span>Between 2000 and 2008, it took on average 12.7 years for a cancer drug to go from getting a patent to being approved for patients in the UK by the health technology assessment body, the National Institute for Health and Care Excellence (NICE). </span></span></span></p>
<p><span><span><span>Between 2009 and 2016 the time from patent to patient increased to 14.1 years, the study found.</span></span></span></p>
<p><span><span><span>The report, which focused on analysing access to cancer drugs in the UK, finds that recent years have seen a boom in new drugs for breast cancer, with 15 licenced from 2000-2016. But some other cancers, such as brain cancer, have had no new drugs licensed since 2000.</span></span></span></p>
<p><span><span><span>“Drugs are taking longer to reach patients when we would expect the process to be getting quicker,” said Olivia Rossanese, head of therapeutics biology at ICR. “With targeted treatments, it should be possible to run smarter, faster trials and to take a more flexible approach to assessing the results for rapid regulatory approval.”</span></span></span></p>
<p><span><span><span>NICE is trying to conduct its cost effectiveness appraisals earlier, often before licensing has been completed, but decisions have barely sped up. Drugs took an average of 16 months to go through NICE appraisal between 2009 and 2016, compared with 16.7 months between 2000 and 2008. The government and the pharmaceutical industry <span><span><a href="https://www.abpi.org.uk/media-centre/news/2018/november/faster-access-to-groundbreaking-medicines-as-major-milestones-reached-in-deal-with-pharmaceutical-industry/">signed an agreement last week</a></span></span> to fast-track the approval process, with a pledge to give patients access to new drugs up to six months earlier. </span></span></span></p>
<p><span><span><span>The number of cancer drug approvals at the European Medicines Agency almost doubled between 2000 and 2016, up from 7.5 products a year from 2000-2008, to 14.6 a year from 2009-2016, the study finds. </span></span></span></p>
<p><span><span><span>But while 97 drugs have received market licences from EMA, they are clustered in particular forms of cancer: 64 drugs have been authorised for blood cancers since 2000, while there were no authorisations at all for brain, oesophageal, bladder or womb cancer, and only one for liver cancer.</span></span></span></p>
<p><span><span><span>For children, there were few new drugs, with only 10 of the 177 EMA drug authorisations labelledfor treating paediatric cancers.</span></span></span></p></div>
</div>
</div>
Tue, 04 Dec 2018 11:05:53 +0000Florin51164 at https://sciencebusiness.netHow Spain is reinventing healthcare around patientshttps://sciencebusiness.net/healthy-measures/how-spain-reinventing-healthcare-around-patients
<span property="schema:name" class="field-wrapper">How Spain is reinventing healthcare around patients</span>
<div class="field-wrapper field field-node--field-author field-name-field-author field-type-entity-reference field-label-hidden">
By
<span class="field-item"><a href="https://sciencebusiness.net/author/eanna-kelly" hreflang="en">Éanna Kelly</a></span></div>
<span class="field-wrapper" rel="schema:author"><span lang="" about="https://sciencebusiness.net/user/9" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">Florin</span></span>
<span property="schema:dateCreated" content="2018-11-06T11:30:24+00:00" class="field-wrapper">06 Nov 2018</span>
<div class="image field field-node--field-image field-name-field-image field-type-image field-label-hidden">
<div class="field-items">
<div class="field-item"> <img property="schema:image" src="https://sciencebusiness.net/sites/default/files/styles/article/public/2018-11/The%20Spanish%20Edge%20-%20cropped2.jpg?itok=cUsCuJj9" width="1050" height="450" alt="" typeof="foaf:Image" /></div>
</div>
</div>
<div property="schema:text" class="body field field-node--body field-name-body field-type-text-with-summary field-label-hidden">
<div class="field-items">
<div property="schema:text" class="field-item"><p><span><span><span>The doctor is a patient’s first and often most personal connection to the rest of the health care system, and the question of how the role should be defined, and how it should be valued, has perhaps never been more urgent. </span></span></span></p>
<p><span><span><span>The idea of value-based healthcare implies a time-consuming and meaningful process of cultivating a relationship with a patient. It is becoming vital to the craft of being a doctor. </span></span></span></p>
<p><span><span><span>This idea is credited to Harvard Business School professor Michael E. Porter and, when boiled down, says that patient satisfaction needs to become an explicit goal for hospitals. While other industries have reinvented themselves around the consumer, in healthcare there is still a huge gap between patients’ expectations and a service delivery stuck in the past. The traditional focus has been on measuring activity in hospitals, rather than the outcomes that matter to patients. </span></span></span></p>
<p><span><span><span>Born in the US, can the concept succeed in Europe?</span></span></span></p>
<p><span><span><span>Spain offers lessons. At a conference in Barcelona on 19 September 2018, patient advocates, doctors, scientists and industry representatives heard about the many experiments underway right now in the country to measure outcomes, analyse data, and reorganise payment systems to benefit from all this.</span></span></span></p>
<blockquote>
<h3><a href="https://sciencebusiness.net/report/how-spain-reinventing-healthcare-around-patients">Get the full report</a></h3>
</blockquote>
<p><span><span><span>Primary care facilities in Spain involved in these experiments are finding the health of patients is improving while the cost of treating them is falling.</span></span></span></p></div>
</div>
</div>
Tue, 06 Nov 2018 11:30:24 +0000Florin51070 at https://sciencebusiness.netHow Spain is reinventing healthcare around patientshttps://sciencebusiness.net/report/how-spain-reinventing-healthcare-around-patients
<span class="field-wrapper">How Spain is reinventing healthcare around patients</span>
<div class="body field field-node--body field-name-body field-type-text-with-summary field-label-hidden">
<div class="field-items">
<div class="field-item"><p><span><span><span>The doctor is a patient’s first and often most personal connection to the rest of the health care system, and the question of how the role should be defined, and how it should be valued, has perhaps never been more urgent. </span></span></span></p>
<p><span><span><span>The idea of value-based healthcare implies a time-consuming and meaningful process of cultivating a relationship with a patient. It is becoming vital to the craft of being a doctor. </span></span></span></p>
<p><span><span><span>This idea is credited to Harvard Business School professor Michael E. Porter and, when boiled down, says that patient satisfaction needs to become an explicit goal for hospitals. While other industries have reinvented themselves around the consumer, in healthcare there is still a huge gap between patients’ expectations and a service delivery stuck in the past. The traditional focus has been on measuring activity in hospitals, rather than the outcomes that matter to patients. </span></span></span></p>
<p><span><span><span>Born in the US, can the concept succeed in Europe?</span></span></span></p>
<p><span><span><span>Spain offers lessons. At a conference in Barcelona on 19 September 2018, patient advocates, doctors, scientists and industry representatives heard about the many experiments underway right now in the country to measure outcomes, analyse data, and reorganise payment systems to benefit from all this.</span></span></span></p>
<p><span><span><span>Primary care facilities in Spain involved in these experiments are finding the health of patients is improving while the cost of treating them is falling.</span></span></span></p></div>
</div>
</div>
<span class="field-wrapper"><span lang="" about="https://sciencebusiness.net/user/9" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">Florin</span></span>
<span class="field-wrapper">06 Nov 2018</span>
<div class="field-wrapper field field-node--field-standfirst field-name-field-standfirst field-type-text-long field-label-hidden">
<div class="field-items">
<div class="field-item"><p><span><span><span><span lang="EN-GB" xml:lang="EN-GB" xml:lang="EN-GB"><span><span>Spain is widely regarded as having one of the world’s best healthcare systems. Can a series of experiments in ‘value-based’ care help to make it even better?</span></span></span></span></span></span></p></div>
</div>
</div>
<div content="0.00" class="field-wrapper field field-node--field-price field-name-field-price field-type-decimal field-label-hidden">
<div class="field-items">
<div content="0.00" class="field-item">€0.00</div>
</div>
</div>
<div class="field-wrapper field field-node--field-report field-name-field-report field-type-file field-label-hidden">
<div class="field-items">
<div class="field-item">/system/files/reports/SB-THE%20SPANISH%20EDGE.pdf</div>
</div>
</div>
<div class="field-wrapper field field-node--field-pages field-name-field-pages field-type-integer field-label-above">
<div class="field-label">Pages</div>
<div class="field-items">
<div class="field-item">12</div>
</div>
</div>
<div class="field-wrapper field field-node--field-cover field-name-field-cover field-type-image field-label-hidden">
<div class="field-items">
<div class="field-item"> <img src="https://sciencebusiness.net/sites/default/files/styles/report_cover_thumbnail/public/reoprts/The%20Spanish%20Edge.jpg?itok=rTTUcSGG" width="180" height="254" alt="" typeof="foaf:Image" /></div>
</div>
</div>
Tue, 06 Nov 2018 11:26:58 +0000Florin51069 at https://sciencebusiness.netNew videos highlight benefits of IMI projectshttps://sciencebusiness.net/healthy-measures/news/new-videos-highlight-benefits-imi-projects
<span property="schema:name" class="field-wrapper">New videos highlight benefits of IMI projects</span>
<span class="field-wrapper" rel="schema:author"><span lang="" about="https://sciencebusiness.net/user/9" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">Florin</span></span>
<span property="schema:dateCreated" content="2018-10-19T08:35:26+00:00" class="field-wrapper">19 Oct 2018</span>
<div class="image field field-node--field-image field-name-field-image field-type-image field-label-hidden">
<div class="field-items">
<div class="field-item"> <img property="schema:image" src="https://sciencebusiness.net/sites/default/files/styles/article/public/2018-10/imi-facts-figures_0.jpg?itok=gDjAMJ3r" width="1050" height="450" alt="" typeof="foaf:Image" /></div>
</div>
</div>
Fri, 19 Oct 2018 08:35:26 +0000Florin51021 at https://sciencebusiness.netWatch IMI’s Stakeholder Forum live online on 24 Octoberhttps://sciencebusiness.net/healthy-measures/news/watch-imis-stakeholder-forum-live-online-24-october-1
<span property="schema:name" class="field-wrapper">Watch IMI’s Stakeholder Forum live online on 24 October</span>
<span class="field-wrapper" rel="schema:author"><span lang="" about="https://sciencebusiness.net/user/9" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">Florin</span></span>
<span property="schema:dateCreated" content="2018-10-19T08:32:39+00:00" class="field-wrapper">19 Oct 2018</span>
<div class="image field field-node--field-image field-name-field-image field-type-image field-label-hidden">
<div class="field-items">
<div class="field-item"> <img property="schema:image" src="https://sciencebusiness.net/sites/default/files/styles/article/public/2018-10/imi%20logo%20wide_4_1.jpg?itok=YoVLrQkQ" width="1050" height="450" alt="" typeof="foaf:Image" /></div>
</div>
</div>
Fri, 19 Oct 2018 08:32:39 +0000Florin51020 at https://sciencebusiness.netIMI publishes draft Call topic textshttps://sciencebusiness.net/healthy-measures/news/imi-publishes-draft-call-topic-texts
<span property="schema:name" class="field-wrapper">IMI publishes draft Call topic texts</span>
<span class="field-wrapper" rel="schema:author"><span lang="" about="https://sciencebusiness.net/user/9" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">Florin</span></span>
<span property="schema:dateCreated" content="2018-10-19T08:30:57+00:00" class="field-wrapper">19 Oct 2018</span>
<div class="image field field-node--field-image field-name-field-image field-type-image field-label-hidden">
<div class="field-items">
<div class="field-item"> <img property="schema:image" src="https://sciencebusiness.net/sites/default/files/styles/article/public/2018-10/imi%20logo%20wide_4.jpg?itok=ZXrm7e_j" width="1050" height="450" alt="" typeof="foaf:Image" /></div>
</div>
</div>
Fri, 19 Oct 2018 08:30:57 +0000Florin51017 at https://sciencebusiness.netPhysician who created ‘Tripadvisor for doctors’ picked to run ICHOMhttps://sciencebusiness.net/healthy-measures/network-news/physician-who-created-tripadvisor-doctors-picked-run-ichom
<span property="schema:name" class="field-wrapper">Physician who created ‘Tripadvisor for doctors’ picked to run ICHOM</span>
<div class="field-wrapper field field-node--field-author field-name-field-author field-type-entity-reference field-label-hidden">
By
<span class="field-item"><a href="https://sciencebusiness.net/author/eanna-kelly" hreflang="en">Éanna Kelly</a></span></div>
<span class="field-wrapper" rel="schema:author"><span lang="" about="https://sciencebusiness.net/user/9" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">Florin</span></span>
<span property="schema:dateCreated" content="2018-10-04T15:03:33+00:00" class="field-wrapper">04 Oct 2018</span>
<div class="image field field-node--field-image field-name-field-image field-type-image field-label-hidden">
<div class="field-items">
<div class="field-item"> <img property="schema:image" src="https://sciencebusiness.net/sites/default/files/styles/article/public/2018-10/NeilBacon23.jpg?itok=9Pg3Era3" width="1050" height="450" alt="" typeof="foaf:Image" /></div>
</div>
</div>
<div class="field-wrapper field field-node--field-image-caption field-name-field-image-caption field-type-text-long field-label-hidden">
<div class="field-items">
<div class="field-item"><p>Neil Bacon, new ICHOM president, CEO</p></div>
</div>
</div>
<div property="schema:text" class="body field field-node--body field-name-body field-type-text-with-summary field-label-hidden">
<div class="field-items">
<div property="schema:text" class="field-item"><p>The International Consortium for Health Outcomes Measurement (ICHOM) on Monday appointed physician-entrepreneur Neil Bacon as its new president and CEO. </p>
<p>ICHOM, a non-profit, was set up to measure, document, and publish meaningful health outcomes about conditions. Bacon succeeds its current head, Christina Akerman, who ran the organisation since 2014.</p>
<p>A nephrologist trained at Oxford and Harvard, Bacon is the creator of iWantGreatCare, a TripAdvisor-style review site that lets patients rate every medic who has treated them.</p>
<p>He has argued that the site, which launched in 2008, forces doctors to listen more to patients, explain themselves better and improve the treatment they provide. Today it features reviews from more than five million patients in 23 countries.</p>
<p>Bacon also created doctors.net.uk, now one of the world’s largest social networking site for clinicians.</p>
<p>In a statement, he said that, "The worldwide need to measure quality and value in healthcare…is greater than ever. The benefits to patients, providers, and payers of measuring the ultimate quality of care is irrefutable."</p>
<p>ICHOM, which has developed outcome standard sets in 26 conditions including stroke, diabetes, and ischemic heart disease, was co-founded in 2012 by Michael Porter, the Harvard economist whose work underpins value-based healthcare, alongside Stefan Larsson of the Boston Consulting Group, and Martin Ingvar of the Karolinska Institute in Sweden.</p>
<p>"Dr Neil Bacon is a pioneer and entrepreneur in use of information technology to enhance quality measurement and change health care," Porter, who authored ‘Redefining Healthcare’, considered a seminal work on the theme of patient-centred care, said in a statement. <br />
</p></div>
</div>
</div>
Thu, 04 Oct 2018 15:03:33 +0000Florin50984 at https://sciencebusiness.netIMI’s eTOX project: ‘We found a way to share the unsharable’https://sciencebusiness.net/healthy-measures/news/imis-etox-project-we-found-way-share-unsharable
<span property="schema:name" class="field-wrapper">IMI’s eTOX project: ‘We found a way to share the unsharable’</span>
<span class="field-wrapper" rel="schema:author"><span lang="" about="https://sciencebusiness.net/user/9" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">Florin</span></span>
<span property="schema:dateCreated" content="2018-08-28T15:19:21+00:00" class="field-wrapper">28 Aug 2018</span>
<div class="image field field-node--field-image field-name-field-image field-type-image field-label-hidden">
<div class="field-items">
<div class="field-item"> <img property="schema:image" src="https://sciencebusiness.net/sites/default/files/styles/article/public/2018-08/etox.jpg?itok=8DFwe1Oy" width="1050" height="450" alt="" typeof="foaf:Image" /></div>
</div>
</div>
Tue, 28 Aug 2018 15:19:21 +0000Florin50896 at https://sciencebusiness.netSign up for the IMI Stakeholder Forum 2018https://sciencebusiness.net/healthy-measures/news/sign-imi-stakeholder-forum-2018
<span property="schema:name" class="field-wrapper">Sign up for the IMI Stakeholder Forum 2018</span>
<span class="field-wrapper" rel="schema:author"><span lang="" about="https://sciencebusiness.net/user/9" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">Florin</span></span>
<span property="schema:dateCreated" content="2018-08-28T15:14:07+00:00" class="field-wrapper">28 Aug 2018</span>
<div class="image field field-node--field-image field-name-field-image field-type-image field-label-hidden">
<div class="field-items">
<div class="field-item"> <img property="schema:image" src="https://sciencebusiness.net/sites/default/files/styles/article/public/2018-08/imi%20logo%20wide_4.jpg?itok=IrsjQAZD" width="1050" height="450" alt="" typeof="foaf:Image" /></div>
</div>
</div>
Tue, 28 Aug 2018 15:14:07 +0000Florin50895 at https://sciencebusiness.net